Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · GLP-1 Weight Loss

LIV Body Review

Flat-rate compounded GLP-1 program from a fitness-led brand with 24/7 clinical support.

Last reviewed July 2026
4 studies cited
Fact-checked 18 July 2026Last updated 15 June 2026From $249 – $499/moEditor Score 4.2 / 5

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

Flat-rate compounded GLP-1 program from a fitness-led brand with 24/7 clinical support.

Who it's for: LIV Body is for buyers who plan to climb through higher GLP-1 doses and want zero pricing surprises along the way. The fitness-influencer brand identity will resonate more with some readers than others.

Bottom line: A premium-priced clinic that earns its rate when you actually titrate up. If you stay on a low dose, cheaper flat-rate clinics deliver the same medication for less.

Pros
  • Flat pricing across every GLP-1 dose
  • 24/7 physician and nurse support
  • No hidden membership fees
Cons
  • Higher monthly entry price
  • Compounded only, no brand-name option
  • Not available in every state

Pros & Cons In Detail

Flat pricing across every GLP-1 dose
That matters because GLP-1 dosing typically titrates upward over the first six months. programs that surcharge by dose can quietly double a monthly bill that started low.
24/7 physician and nurse support
In practice this is one of the differentiators that pushes LIV Body's editor score above the category median.
No hidden membership fees
In practice this is one of the differentiators that pushes LIV Body's editor score above the category median.
Higher monthly entry price
Cost is in line with category leaders, not below them. readers shopping primarily on monthly out-of-pocket should weigh the alternatives in the listicle.
Compounded only, no brand-name option
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Not available in every state
Up-front lab work adds days to onboarding and a few dollars to the first month, although most clinicians would argue this is a feature rather than a bug.

LIV Body Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at LIV Body.

Program / Membership FeeIncluded in monthly plan
Medication Cost (From)From $249 – $499/mo
What This Means For You

LIV Body uses a flat monthly rate that does not change as patients titrate up through GLP-1 doses. Brand-name medications are not offered; the higher entry price reflects the dose-flat structure.

Who LIV Body Is For

LIV Body is for buyers who plan to climb through higher GLP-1 doses and want zero pricing surprises along the way. The fitness-influencer brand identity will resonate more with some readers than others.

How LIV Body Markets Itself

Adults who expect to titrate through higher GLP-1 doses and want guaranteed flat pricing across the entire dose ladder.

Signature Programs

  • ›Flat-rate compounded semaglutide
  • ›Flat-rate compounded tirzepatide
  • ›24/7 physician and nurse support

Medication Formulary

Full Formulary
compounded semaglutidecompounded tirzepatide

The Bottom Line

A premium-priced clinic that earns its rate when you actually titrate up. If you stay on a low dose, cheaper flat-rate clinics deliver the same medication for less.

With an editor score of 4.2 / 5 across cost, experience, and trust, LIV Body is one of the strong mid-tier options in the glp-1 weight loss category we cover.

See how LIV Body compares in our full glp-1 weight loss rankings, or read the Best Compounded GLP-1 Telehealth Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
  3. Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
  4. FDA Federal Register 2024 (Tirzepatide shortage end) · FDA removed tirzepatide from the drug shortage list in October 2024.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

Alternatives To LIV Body

§ Continue Reading